The role of microglia heterogeneity in synaptic plasticity and brain disorders: Will sequencing shed light on the discovery of new therapeutic targets?

Y You, Z Chen, WW Hu - Pharmacology & Therapeutics, 2024 - Elsevier
Microglia play a crucial role in interacting with neuronal synapses and modulating synaptic
plasticity. This function is particularly significant during postnatal development, as microglia …

The role and control of arginine levels in arginase 1 deficiency

GA Diaz, M Bechter… - Journal of Inherited …, 2023 - Wiley Online Library
Abstract Arginase 1 Deficiency (ARG1‐D) is a rare urea cycle disorder that results in
persistent hyperargininemia and a distinct, progressive neurologic phenotype involving …

The Biocatalysis in Cancer Therapy

J Liu, H Ren, T Tang, J Wang, J Fang, C Huang… - ACS …, 2023 - ACS Publications
Biocatalysis can be defined as the use of isolated enzymes or enzymes inside cells to
convert substrates into products. The term “biocatalysis” is often used in modern organic …

[HTML][HTML] Challenges and strategies for clinical trials in propionic and methylmalonic acidemias

J Vockley, B Burton, A Jurecka, J Ganju, B Leiro… - Molecular Genetics and …, 2023 - Elsevier
Clinical trial development in rare diseases poses significant study design and methodology
challenges, such as disease heterogeneity and appropriate patient selection, identification …

Childhood-onset hereditary spastic paraplegia and its treatable mimics

D Ebrahimi-Fakhari, A Saffari, PL Pearl - Molecular genetics and …, 2022 - Elsevier
Early-onset forms of hereditary spastic paraplegia and inborn errors of metabolism that
present with spastic diplegia are among the most common “mimics” of cerebral palsy. Early …

Safety, PK/PD and preliminary anti-tumor activities of pegylated recombinant human arginase 1 (BCT-100) in patients with advanced arginine auxotrophic tumors

PNM Cheng, AM Liu, A Bessudo, F Mussai - Investigational New Drugs, 2021 - Springer
Background The study determined the safety, pharmacokinetics/pharmacodynamics
(PK/PD), and recommended Phase II dose of BCT-100 for arginine auxotrophic tumours in a …

Metabolism in tumor-associated macrophages

J Li, GM DeNicola, B Ruffell - International review of cell and molecular …, 2022 - Elsevier
Macrophages functionally adapt to a diverse set of signals, a process that is critical for their
role in maintaining or restoring tissue homeostasis. This process extends to cancer, where …

Human arginase 1, a Jack of all trades?

J Anakha, PS Kawathe, S Datta, SS Jawalekar… - 3 Biotech, 2022 - Springer
Arginine, a conditionally essential amino acid, plays a crucial role in several metabolic and
signalling pathways. Arginine metabolism in the body can be significantly increased under …

Societal costs and quality of life associated with arginase 1 deficiency in a European setting–a multinational, cross-sectional survey

S Olofsson, S Löfvendahl, J Widén… - Journal of Medical …, 2024 - Taylor & Francis
Background and aims Arginase 1 deficiency (ARG1-D) is a ultrarare disease with
manifestations that cause mobility and cognitive impairment that progress over time and may …

Efficacy and safety of pegzilarginase in arginase 1 deficiency (PEACE): a phase 3, randomized, double-blind, placebo-controlled, multi-centre trial

RS Russo, S Gasperini, G Bubb, L Neuman… - …, 2024 - thelancet.com
Summary Background Arginase 1 Deficiency (ARG1-D) is a rare debilitating, progressive,
inherited, metabolic disease characterized by marked increases in plasma arginine (pArg) …